| scholarly article | Q13442814 |
| P50 | author | Leaf Huang | Q16221564 |
| Tyler Goodwin | Q86022511 | ||
| Manisit Das | Q88778515 | ||
| P2093 | author name string | Qi Liu | |
| Lei Miao | |||
| Rihe Liu | |||
| Jingjing Li | |||
| Oleksandra Dorosheva | |||
| C Michael Lin | |||
| Richard Feng | |||
| P2860 | cites work | Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy | Q89700462 |
| Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 | Q27651269 | ||
| Structure and Interactions of the Human Programmed Cell Death 1 Receptor | Q27676419 | ||
| Development and preclinical characterization of a humanized antibody targeting CXCL12 | Q27685150 | ||
| NMR structure of a parallel homotrimeric coiled coil | Q27765078 | ||
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer | Q29547638 | ||
| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine | Q29616728 | ||
| Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients | Q29617771 | ||
| MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer | Q29617772 | ||
| Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. | Q30377799 | ||
| Role of STAT3 in cancer metastasis and translational advances | Q31142794 | ||
| Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
| HMGB1 release and redox regulates autophagy and apoptosis in cancer cells | Q34154797 | ||
| Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. | Q34163076 | ||
| Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts | Q34358613 | ||
| Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer | Q34387974 | ||
| Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer | Q34479313 | ||
| Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma | Q35329190 | ||
| Pathological and molecular evaluation of pancreatic neoplasms | Q35670143 | ||
| Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model. | Q35739956 | ||
| Programmed death ligand 2 in cancer-induced immune suppression. | Q35955151 | ||
| Immunotherapy for pancreatic cancer - science driving clinical progress | Q36133140 | ||
| Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin | Q36217643 | ||
| Tissue expression of PD-L1 mediates peripheral T cell tolerance. | Q36228541 | ||
| Macrophage polarization comes of age. | Q36287066 | ||
| Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors | Q36402716 | ||
| Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer | Q36550798 | ||
| Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response | Q36659314 | ||
| What is recent in pancreatic cancer immunotherapy? | Q36665335 | ||
| Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy | Q36693506 | ||
| Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection | Q36935291 | ||
| The tumor microenvironment and its role in promoting tumor growth | Q36946019 | ||
| Advancements in immune tolerance | Q36988746 | ||
| mTORC2 mediates CXCL12-induced angiogenesis | Q37123901 | ||
| Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis | Q37254863 | ||
| Harnessing immune responses in the tumor microenvironment: all signals needed | Q37340543 | ||
| Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength | Q37364714 | ||
| Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer | Q37600068 | ||
| Tumor delivery of macromolecular drugs based on the EPR effect | Q37715368 | ||
| Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment | Q37731681 | ||
| Pancreatic cancer: understanding and overcoming chemoresistance | Q37811882 | ||
| Functional phenotypes of macrophages and the M1-M2 polarization concept. Part I. Proinflammatory phenotype. | Q38026897 | ||
| NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer | Q38088677 | ||
| The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease | Q38223391 | ||
| Tumor-associated macrophages as major players in the tumor microenvironment | Q38240110 | ||
| CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks | Q38472331 | ||
| Stromal biology and therapy in pancreatic cancer: a changing paradigm | Q38494338 | ||
| Renal metastasis from pancreatic adenocarcinoma: a rare case along with literature review | Q38578191 | ||
| Immune-related adverse events with immune checkpoint blockade: a comprehensive review | Q38696141 | ||
| Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors | Q38730195 | ||
| Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs | Q38827765 | ||
| CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property | Q38861083 | ||
| Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver | Q38873616 | ||
| Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha | Q39635625 | ||
| Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells. | Q39751289 | ||
| Transport of molecules in the tumor interstitium: a review | Q39768023 | ||
| Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model. | Q39994717 | ||
| Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo | Q40166130 | ||
| Local and transient gene expression primes the liver to resist cancer metastasis | Q41028280 | ||
| PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. | Q42017650 | ||
| Structural and functional analysis of the costimulatory receptor programmed death-1. | Q47926421 | ||
| The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors | Q50579985 | ||
| Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach | Q50646515 | ||
| Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma | Q50918196 | ||
| Thymoquinone Ameliorates Cadmium-Induced Nephrotoxicity, Apoptosis, and Oxidative Stress in Rats is Based on its Anti-Apoptotic and Anti-Oxidant Properties | Q52927233 | ||
| Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer | Q56896104 | ||
| Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer | Q60609502 | ||
| Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells | Q81816127 | ||
| Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice | Q82772904 | ||
| Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer | Q83348551 | ||
| Pancreatic cancer: Dodging immunosuppression | Q87987908 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8690-8706 | |
| P577 | publication date | 2017-08-28 | |
| P1433 | published in | ACS Nano | Q2819067 |
| P1476 | title | Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer | |
| P478 | volume | 11 |
| Q89983778 | Advanced biomaterials for cancer immunotherapy |
| Q47389306 | BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. |
| Q57180634 | Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade |
| Q64272058 | Emerging Nano-/Microapproaches for Cancer Immunotherapy |
| Q60923345 | Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy |
| Q47732542 | Immunoengineering with biomaterials for enhanced cancer immunotherapy |
| Q90437022 | Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers |
| Q90279252 | Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma |
| Q48646732 | Nanomaterials for cancer immunotherapy. |
| Q48164881 | Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma |
| Q95642943 | Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer |
| Q90628293 | Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms |
| Q52559698 | Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer. |
| Q91665456 | Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy |
| Q96304746 | Supramolecular Self-Assembled Nanostructures for Cancer Immunotherapy |
| Q55046482 | Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. |
| Q52579251 | Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment. |
| Q99624572 | Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth |
Search more.